Gulf Drug is proud to announce it has been presented with the BDI Growth Award during the BDI Partner Forum held in Dubai on 23 September 2025 and received by the Medical Supplies and Instruments Business Team. The award recognises organisations that demonstrate exceptional growth, scalable operations, and contribution to healthcare access in the region.
Gulf Drug was selected for the award in recognition of its recent performance across multiple dimensions: year-on-year market expansion, enhancements to supply-chain resilience, adoption of digital inventory forecasting, and strengthened partnerships with manufacturers and healthcare providers. These initiatives have helped improve product availability and delivery timelines across the GCC.
The award was presented at the BDI Partner Forum — a gathering of industry leaders and partner organisations focused on collaboration, governance, and sustainable growth within the Gulf region. Gulf Drug plans to build on this momentum by accelerating digital transformation initiatives and further expanding its distribution footprint across the GCC.
